Howard B. Goldman is a Professor on the faculty of the Cleveland Clinic Lerner College of Medicine and an expert in quality and patient safety serving as the Institute Vice Chairman for Clinical Affairs at the Glickman Urologic Institute. He served as interim Chairman of the department from 2024 to 2025. He has a joint appointment in the departments of urology and obstetrics and gynecology and is actively involved in the training of fellows and residents, including serving as the Fellowship director for Female Pelvic Medicine and Reconstructive Surgery in the Department of Urology at the Cleveland Clinic. He has directly trained over 40 fellows and residents who are specialized FPMRS practitioners. Many of these fellows have assumed leadership roles in academic urology and many have also become quality and patient safety experts at their local institutions.
Dr Goldman’s interests are in the medical and surgical treatment of urinary incontinence and other types of voiding dysfunction, neuromodulation, prolapse repair, complex reconstructive female urologic surgery, robotic surgery and neurourology. His contributions to the literature have been prolific, including author of over 250 articles and book chapters, editor of three textbooks and panel member for a number of standardization, guidelines and best practice statement panels. He has deliverd over 500 national and international lectures. He has been at the forefront of outpatient robotic surgery within FPMRS. Within the AUA he has been on the SUI Guidelines as well as Urodynamics guidelines committees. Within ICS he has been on the male LUTS terminology committee as well as the ICS/IUGA female prolapse terminology committee. He also led the group that came up with the ICS sacral neuromodulation best practices document.
His prominent international reputation has led to invitations as visiting professor in the United States and abroad as well as numerous invited lectures. He is on the editorial board of a number of journals and is a former Assistant Editor of the Journal of Urology.
He has been the co-director of the AUA annual review course for part 1 of the ABU exam for 10 years, was on the AUA Education committee, is on the SUFU board of directors, was on the International Neurourology board of directors, is on the IUGA scientific committee, is the Chair of the ICS Education committee, was the scientific co-chair for the 2020 ICS annual meeting, was the program co-chair for the 2020 SUFU meeting, was on the program committee for the 2020 International Neurourology Society and is the International Consultation on Incontinence committee chair for surgery for male incontinence.
Dr Goldman has been involved in and led numerous projects related to innovative treatments utilizing stem cells for SUI, neuromodulation, utilization of urodynamics, management of complications, robotic surgery and improvements in safety and efficiency in pelvic floor surgery. Recently, he was the clinical lead on an innovative urodynamics device which can stay in the bladder and record events for up to 24 hours without any external catheters. He is also leading a study on the efficacy of sacral neuromodulation in patients with cognitive impairment.
Dr. Goldman is an astute physician-scientist, nurturing educator, model leader, and unwavering patient advocate renowned in the field of urology.